News for Kyverna Therapeutics Inc Stock (KYTX)

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 7, 2025 in Kyverna Therapeutics, Inc. Lawsuit - KYTX

Accesswire • Saturday

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Case Against Kyverna Therapeutics Inc

Accesswire • Saturday

Class Action Announcement (KYTX): A Securities Fraud Class Action Lawsuit Was Filed Against Kyverna Therapeutics, Inc. (KYTX)

Accesswire • Saturday

KYTX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

GlobeNewsWire • Saturday

KYVERNA THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. - KYTX

PRNewsWire • Saturday

ROSEN, A TOP RANKED LAW FIRM, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – KYTX

GlobeNewsWire • Saturday

Levi & Korsinsky Reminds Kyverna Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025 - KYTX

Accesswire • Friday

Levi & Korsinsky Reminds Kyverna Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 202- KYTX

Accesswire • Friday

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Kyverna Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - KYTX

PRNewsWire • Friday

February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTX

Accesswire • Friday

KYTX Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Kyverna Therapeutics, Inc. - Contact Kessler Topaz Meltzer & Check, LLP

GlobeNewsWire • Friday

Kyverna Therapeutics Inc. Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Contact The Schall Law Firm

Accesswire • Friday

Class Action Filed Against Kyverna Therapeutics, Inc. (KYTX) - February 7, 2025 Deadline to Join - Contact Levi & Korsinsky

Accesswire • Friday

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kyverna Therapeutics, Inc. (KYTX)

GlobeNewsWire • Friday

Levi & Korsinsky Notifies Shareholders of Kyverna Therapeutics, Inc. (KYTX) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire • Friday

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics

GlobeNewsWire • Friday

Kyverna Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Kyverna Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025 - KYTX

Accesswire • Friday

KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

Accesswire • Friday

Class Action Filed Against Kyverna Therapeutics, Inc. (KYTX) Seeking Recovery for Investors - Contact Levi & Korsinsky

PRNewsWire • Friday

Kyverna Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - KYTX

Accesswire • Friday

KYVERNA THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. - KYTX

Accesswire • Friday

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 7, 2025 in Kyverna Therapeutics, Inc. Lawsuit - KYTX

Accesswire • Thursday

Kyverna Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 7, 2025 to Discuss Your Rights – KYTX

Accesswire • Thursday

KYTX INVESTOR DEADLINE: Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

PRNewsWire • Thursday

Shareholders of Kyverna Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 7, 2025 to Discuss Your Rights - KYTX

Accesswire • Thursday